Published in Am J Transplant on January 01, 2006
Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis | NCT02632123
The prognostic value of kidney transplant center report cards. Am J Transplant (2013) 2.64
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model. Cancer (2014) 2.26
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04
Waiting list mortality among children listed for heart transplantation in the United States. Circulation (2009) 1.77
Survival after liver transplantation in the United Kingdom and Ireland compared with the United States. Gut (2007) 1.51
Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant (2010) 1.38
High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest (2009) 1.22
Impact of MELD-based allocation on end-stage renal disease after liver transplantation. Am J Transplant (2011) 1.17
Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol (2011) 1.16
Patient-specific prediction of ESRD after liver transplantation. J Am Soc Nephrol (2013) 1.04
Hospitalizations following living donor nephrectomy in the United States. Clin J Am Soc Nephrol (2014) 1.00
Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol (2013) 0.99
Donor polymorphisms of toll-like receptor 4 associated with graft failure in liver transplant recipients. Liver Transpl (2012) 0.95
Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis. Clin J Am Soc Nephrol (2014) 0.94
Outcome differences across transplant centers: comparison of two methods for public reporting. Clin J Am Soc Nephrol (2011) 0.94
Prominent impact of community risk factors on kidney transplant candidate processes and outcomes. Am J Transplant (2013) 0.91
Comorbidity burden and perioperative complications for living kidney donors in the United States. Clin J Am Soc Nephrol (2013) 0.89
Hodgkin lymphoma among US solid organ transplant recipients. Transplantation (2010) 0.88
Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction. Liver Transpl (2016) 0.88
Emergency Department Visits after Kidney Transplantation. Clin J Am Soc Nephrol (2016) 0.86
Outcomes of Live Kidney Donors Who Develop End-Stage Renal Disease. Transplantation (2016) 0.84
Variation in access to the liver transplant waiting list in the United States. Transplantation (2014) 0.83
Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality. Am J Transplant (2016) 0.82
Liver grafts for transplantation from donors with diabetes: an analysis of the Scientific Registry of Transplant Recipients database. PLoS One (2014) 0.82
Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score. Liver Transpl (2012) 0.79
Utilization of Deceased Donor Kidneys to Initiate Living Donor Chains. Am J Transplant (2016) 0.78
Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database. PLoS One (2016) 0.78
Intent-to-treat analysis of liver transplant for hepatocellular carcinoma in the MELD era: impact of hepatitis C and advanced status. Dig Dis Sci (2014) 0.78
Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology (2016) 0.77
Redesigning Organ Allocation Boundaries for Liver Transplantation in the United States. Proc Int Conf Health Care Syst Eng (2013) (2015) 0.75
Influence of donor-recipient sex mismatch on long-term survival of pancreatic grafts. Sci Rep (2016) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Development of the new lung allocation system in the United States. Am J Transplant (2006) 4.02
Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis (1997) 2.63
Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Cancer incidence among Canadian kidney transplant recipients. Am J Transplant (2007) 1.66
Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant (2010) 1.55
Kidney and pancreas transplantation in the United States, 1999-2008: the changing face of living donation. Am J Transplant (2010) 1.55
Repeat organ transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.50
Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48
Kidney and pancreas transplantation in the United States, 1997-2006: the HRSA Breakthrough Collaboratives and the 58 DSA Challenge. Am J Transplant (2008) 1.38
Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant (2010) 1.38
Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35
Physical activity, physical fitness, and risk of dying. Epidemiology (1998) 1.24
Predictability of survival models for waiting list and transplant patients: calculating LYFT. Am J Transplant (2009) 1.22
Impact of MELD-based allocation on end-stage renal disease after liver transplantation. Am J Transplant (2011) 1.17
Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. Am J Transplant (2007) 1.09
Transplants in Foreign Countries Among Patients Removed from the US Transplant Waiting List. Am J Transplant (2008) 1.05
SRTR program-specific reports on outcomes: a guide for the new reader. Am J Transplant (2008) 1.02
Sex-based disparities in liver transplant rates in the United States. Am J Transplant (2011) 1.02
Liver and intestine transplantation in the United States, 1995-2004. Am J Transplant (2006) 0.99
A practical approach to evaluate the potential donor pool and trends in cadaveric kidney donation. Transplantation (1999) 0.93
Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period. Am J Transplant (2008) 0.93
Radon-progeny exposure and lung cancer risk in a cohort of Newfoundland fluorspar miners. Radiat Res (1998) 0.91
The incidence of cancer in a population-based cohort of Canadian heart transplant recipients. Am J Transplant (2010) 0.91
Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis (2000) 0.86
Efficient utilization of the expanded criteria donor (ECD) deceased donor kidney pool: an analysis of the effect of labeling. Am J Transplant (2010) 0.84
Introduction to the excerpts from the United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis (1999) 0.80
Developing organ offer and acceptance measures: when 'good' organs are turned down. Am J Transplant (2007) 0.80
The effect of small solute clearances on survival of anuric peritoneal dialysis patients. Perit Dial Int (2000) 0.77
Peritoneal dialysis reduces the use of non native fistula access in dialysis programs. Adv Perit Dial (1999) 0.77
Practical examples and data for upgrading buildings in the health estate. Hosp Eng (1978) 0.75